[Essential phospholipids in combined therapy of chronic circulatory insufficiency].
Essential phospholipids (essentiale-forte) was used in combined therapy of 36 patients with pronounced circulatory insufficiency and hepatic dysfunction. A 4-6-week course of this treatment 6 weeks after its termination resulted in good subjective response, positive changes in hemodynamics, intrahepatic cholestasis, synthetic function of the liver and lipid metabolism. The drug was well tolerated.